Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
Select bar for recommendation details.
Recommendations | 14-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 2 | |
Hold | 2 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 3 analysts offering 12 month price targets for Amphastar Pharmaceuticals Inc have a median target of 55.00, with a high estimate of 66.00 and a low estimate of 55.00. The median estimate represents a 23.46% increase from the last price of 44.55.
High | 48.1% | 66.00 |
Med | 23.5% | 55.00 |
Low | 23.5% | 55.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 26, 2025.
Average growth rate | -3.20% |
Average growth rate | +76.04% |
More ▼
Revenue history & estimates in USD
Average growth rate | +1.53% |
Average growth rate | +19.20% |
More ▼